You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Augmented Reality Training Tools with Realistic Animations and Voice Navigation on Tablet and AR Headset for Combat Casualty Care

    SBC: SHARP VISION SOFTWARE LLC            Topic: DHP163002

    Development of Augmented Reality (AR) training tools for combat casualty care with realistic animations and voice navigation capability on tablets and AR headset is proposed to enhance the tools that have already been developed during the Phase II effort on fasciotomy, cricothyroidotomy, and lateral canthotomy. Such enhancements are made possible by the recent advancement in both hardware and soft ...

    SBIR Phase II 2023 Department of DefenseDefense Health Agency
  2. Steerable Check Tube and Portable Suction/Infusion Machine for the Prevention of Retained Hemothorax after Injury

    SBC: SIM-VIVO LLC            Topic: DHP16011

    For all traumatic wounds in the military and civilian population, injuries to the chest are seen in about 60%. Fortunately, nearly 90% of all chest injuries can be treated non-operatively through chest decompression (chest tubes) and adequate pain control. Residual blood in the chest after drainage (retained hemothorax) can result in a persistent clot, constricting fibrin peel, pneumonia, and in t ...

    SBIR Phase II 2023 Department of DefenseDefense Health Agency
  3. Novel Aerosol Therapy for Immediate and Sustained ARDS Management

    SBC: ZYMERON CORP            Topic: DHA231004

    The acute respiratory distress syndrome (ARDS) is a common cause of respiratory failure in critically ill patients and is characterized by failure of oxygen (O2) and carbon dioxide (CO2) movement (gas exchange) across the alveolar-capillary membrane. Despite its high mortality rate of 30-50%, there are currently no definitive pharmacologic therapies for ARDS. Thus, there is a pressing requirement ...

    SBIR Phase I 2023 Department of DefenseDefense Health Agency
  4. Development for ShockDefender against Hemorrhagic Shock

    SBC: ZYMERON CORP            Topic: DHA234D001

    Hemorrhagic shock is responsible for over 35% of prehospital traumatic deaths and over 40% of all deaths within the first 24 hours following injury. Multiple intervention strategies are necessary for prolonged prehospital management and improved casualty survivability including improved blood products, hemostatics, damage control resuscitation, as well as therapeutic interventions targeting coagul ...

    SBIR Phase II 2023 Department of DefenseDefense Health Agency
  5. Far-Forward Austere Sterilizer (FAST)

    SBC: LYNNTECH INC.            Topic: DHA213006

    Sterilization of medical and surgical tools is a critical step in minimizing the risk of infection to combat casualties during far-forward medical interventions. However, there are significant challenges to providing sterile equipment in austere environments where power is limited and ability to transport equipment and deliver supplies is constrained. The complexity of modern surgical tools, such ...

    SBIR Phase II 2023 Department of DefenseDefense Health Agency
  6. Ankle EVAL-ASSIST Portable Technology to Assess Ankle Instability

    SBC: LYNNTECH INC.            Topic: DHA231002

    The DoD as a whole seeks the capability to optimally and rapidly return to duty the high rates of Warfighters with destabilizing lower limb injuries and conditions, the most prevalent injury being acute lateral ankle sprains and chronic ankle instability. Over 70% of the general population experience acute ankle sprains in their life, and the rate of ankle sprains in military personnel is nearly f ...

    SBIR Phase I 2023 Department of DefenseDefense Health Agency
  7. Enteric Respiration Replacement Life Support (ERRLS)

    SBC: LYNNTECH INC.            Topic: DHA231004

    The Department of Defense is solicitating an alternative to extracorporeal membrane oxygenation (ECMO) that is minimally invasive and can be implemented in austere conditions to treat acute respiratory distress syndrome (ARDS). Service members that are deployed and suffer from significant damage may need respiratory and circulatory supplementation until they can be transported to a facility with a ...

    SBIR Phase I 2023 Department of DefenseDefense Health Agency
  8. Digital Human Model for Use in Simulation Environments for Tactile Human/Robot Interactions

    SBC: CORVID TECHNOLOGIES, LLC            Topic: DHA213008

    Corvid Technologies, LLC and Stevens Institute of Technology (Stevens) propose to utilize the results and lessons learned from the Phase I effort to develop and demonstrate a digital human body model capable of quantifying internal stresses and strains in the anatomy and joint loads due to externally applied forces from robotic manipulation. Similar to the approach in Phase I, the proposed approac ...

    SBIR Phase II 2023 Department of DefenseDefense Health Agency
  9. Extreme Cold Simulation Training Environment for Medic Education (ECSTREME)

    SBC: VCOM3D INC            Topic: DHA232003

    For this Phase I SBIR project, Vcom3D will research and develop a modular, proof-of-concept Mixed Reality (MR) Extreme Cold Simulation Trainer for Medic Education (ECSTREME). The system will build on available Modular Healthcare Simulation and Education System (MoHSES) open standards, interoperable modules, and open-source resources. We will demonstrate and evaluate a proof-of-concept ECSTREME sys ...

    SBIR Phase I 2023 Department of DefenseDefense Health Agency
  10. Deployable Wound Care Products to Decrease Preventable Death Outcomes by Mitigating Infection on Battlefield and through Long Term Care

    SBC: KERICURE INC            Topic: DHA201D001

    The work effort in this Sequential Phase II supports the DHA objective of managing large surface area burn wounds in austere and prolonged field care (PFC) environments. KeriCure Medical’s spray on wound dressing technology, to be marketed under the brand name Field Shield, has been optimized to support combat casualty care’s efforts to improve management of large numbers of burn casualties at ...

    SBIR Phase II 2023 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government